

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 5.46086112 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.35380489 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.99416895 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.88206789 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.59544330 |
| 6 | sodium ion export (GO:0071436) | 4.52402050 |
| 7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.45520201 |
| 8 | positive regulation of synapse maturation (GO:0090129) | 4.32524357 |
| 9 | cellular potassium ion homeostasis (GO:0030007) | 4.29063908 |
| 10 | vocalization behavior (GO:0071625) | 4.22386703 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.09360269 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.06698156 |
| 13 | glutamate secretion (GO:0014047) | 4.06505074 |
| 14 | cerebellar granule cell differentiation (GO:0021707) | 4.00673449 |
| 15 | cell communication by electrical coupling (GO:0010644) | 3.99973153 |
| 16 | neuronal action potential propagation (GO:0019227) | 3.98710868 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 3.97813074 |
| 18 | oxaloacetate metabolic process (GO:0006107) | 3.93498387 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 3.89776757 |
| 20 | activation of protein kinase A activity (GO:0034199) | 3.89483377 |
| 21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.85321584 |
| 22 | neurotransmitter secretion (GO:0007269) | 3.85271662 |
| 23 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.81803038 |
| 24 | potassium ion import (GO:0010107) | 3.76400360 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 3.70930541 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 3.69418714 |
| 27 | exploration behavior (GO:0035640) | 3.68395441 |
| 28 | regulation of histone H3-K27 methylation (GO:0061085) | 3.68387151 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.68177815 |
| 30 | glycine transport (GO:0015816) | 3.65556048 |
| 31 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.61536601 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.60589199 |
| 33 | gamma-aminobutyric acid transport (GO:0015812) | 3.59458615 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.54343271 |
| 35 | neuromuscular process controlling posture (GO:0050884) | 3.48273682 |
| 36 | proline transport (GO:0015824) | 3.44822709 |
| 37 | cell communication involved in cardiac conduction (GO:0086065) | 3.40052541 |
| 38 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.37584671 |
| 39 | amino acid import (GO:0043090) | 3.35340520 |
| 40 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.32701352 |
| 41 | regulation of synapse maturation (GO:0090128) | 3.30258393 |
| 42 | cellular sodium ion homeostasis (GO:0006883) | 3.28788594 |
| 43 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.27539781 |
| 44 | neuromuscular process controlling balance (GO:0050885) | 3.26938354 |
| 45 | creatine metabolic process (GO:0006600) | 3.24416101 |
| 46 | long-term memory (GO:0007616) | 3.23961756 |
| 47 | potassium ion homeostasis (GO:0055075) | 3.16594554 |
| 48 | vitamin transmembrane transport (GO:0035461) | 3.13027035 |
| 49 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11590249 |
| 50 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.10967743 |
| 51 | neurotransmitter transport (GO:0006836) | 3.09748378 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.07974132 |
| 53 | membrane repolarization (GO:0086009) | 3.06993898 |
| 54 | regulation of mitotic spindle organization (GO:0060236) | 3.05307690 |
| 55 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.03830982 |
| 56 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.02975208 |
| 57 | myelin maintenance (GO:0043217) | 3.02926151 |
| 58 | regulation of ARF protein signal transduction (GO:0032012) | 3.02413995 |
| 59 | regulation of early endosome to late endosome transport (GO:2000641) | 3.02040812 |
| 60 | proline biosynthetic process (GO:0006561) | 3.00171926 |
| 61 | prepulse inhibition (GO:0060134) | 2.99487248 |
| 62 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.99363933 |
| 63 | regulation of membrane repolarization (GO:0060306) | 2.98985453 |
| 64 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.98453616 |
| 65 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.96171348 |
| 66 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95066855 |
| 67 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.94605428 |
| 68 | regulation of neurotransmitter levels (GO:0001505) | 2.93254457 |
| 69 | cell volume homeostasis (GO:0006884) | 2.92974995 |
| 70 | protein localization to synapse (GO:0035418) | 2.90440005 |
| 71 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.86538679 |
| 72 | lysine catabolic process (GO:0006554) | 2.86260613 |
| 73 | lysine metabolic process (GO:0006553) | 2.86260613 |
| 74 | synaptic transmission, glutamatergic (GO:0035249) | 2.86024726 |
| 75 | cerebellar Purkinje cell layer development (GO:0021680) | 2.85730346 |
| 76 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.82945340 |
| 77 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.82600635 |
| 78 | positive regulation of sodium ion transport (GO:0010765) | 2.82330449 |
| 79 | auditory behavior (GO:0031223) | 2.81348488 |
| 80 | desmosome organization (GO:0002934) | 2.80457454 |
| 81 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.80097309 |
| 82 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.78720441 |
| 83 | positive regulation of potassium ion transport (GO:0043268) | 2.77232519 |
| 84 | lung epithelium development (GO:0060428) | 2.75797265 |
| 85 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.74305142 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 2.73895813 |
| 87 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.73398628 |
| 88 | regulation of translational fidelity (GO:0006450) | 2.73338148 |
| 89 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.72664979 |
| 90 | proline metabolic process (GO:0006560) | 2.72062167 |
| 91 | glutamate receptor signaling pathway (GO:0007215) | 2.71221954 |
| 92 | dopamine receptor signaling pathway (GO:0007212) | 2.70980909 |
| 93 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.70938349 |
| 94 | membrane depolarization during action potential (GO:0086010) | 2.70748187 |
| 95 | axon ensheathment in central nervous system (GO:0032291) | 2.70300147 |
| 96 | central nervous system myelination (GO:0022010) | 2.70300147 |
| 97 | regulation of cholesterol homeostasis (GO:2000188) | 2.68964272 |
| 98 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.68499977 |
| 99 | alanine transport (GO:0032328) | 2.67339942 |
| 100 | neuron-neuron synaptic transmission (GO:0007270) | 2.66839314 |
| 101 | mating behavior (GO:0007617) | 2.66166584 |
| 102 | L-amino acid import (GO:0043092) | 2.65744988 |
| 103 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.65190925 |
| 104 | tricarboxylic acid cycle (GO:0006099) | 2.64980911 |
| 105 | sodium ion homeostasis (GO:0055078) | 2.64943384 |
| 106 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.64515553 |
| 107 | neuronal ion channel clustering (GO:0045161) | 2.64220598 |
| 108 | fructose metabolic process (GO:0006000) | 2.63673940 |
| 109 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.63628409 |
| 110 | Golgi transport vesicle coating (GO:0048200) | 2.63607574 |
| 111 | COPI coating of Golgi vesicle (GO:0048205) | 2.63607574 |
| 112 | regulation of synaptic plasticity (GO:0048167) | 2.63231957 |
| 113 | NADH metabolic process (GO:0006734) | 2.63124663 |
| 114 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.62604022 |
| 115 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.61804521 |
| 116 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.61787721 |
| 117 | response to parathyroid hormone (GO:0071107) | 2.61228714 |
| 118 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.60848737 |
| 119 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.59674548 |
| 120 | carnitine shuttle (GO:0006853) | 2.59621473 |
| 121 | membrane repolarization during action potential (GO:0086011) | 2.59061395 |
| 122 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.58879414 |
| 123 | aspartate family amino acid catabolic process (GO:0009068) | 2.57756731 |
| 124 | regulation of postsynaptic membrane potential (GO:0060078) | 2.56511277 |
| 125 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.56288917 |
| 126 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.56265375 |
| 127 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.56265375 |
| 128 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.55311117 |
| 129 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.55134473 |
| 130 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.54965227 |
| 131 | chemosensory behavior (GO:0007635) | 2.54028913 |
| 132 | vesicle transport along microtubule (GO:0047496) | 2.53847575 |
| 133 | succinate metabolic process (GO:0006105) | 2.53766472 |
| 134 | dendrite morphogenesis (GO:0048813) | 2.53586605 |
| 135 | regulation of protein dephosphorylation (GO:0035304) | 2.53528142 |
| 136 | phosphate ion transmembrane transport (GO:0035435) | 2.52905997 |
| 137 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.52133851 |
| 138 | dendritic spine organization (GO:0097061) | 2.50992428 |
| 139 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.50879739 |
| 140 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.49574476 |
| 141 | neurotransmitter catabolic process (GO:0042135) | 2.49383935 |
| 142 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.48346842 |
| 143 | activation of Rac GTPase activity (GO:0032863) | 2.47551604 |
| 144 | positive regulation of protein dephosphorylation (GO:0035307) | 2.47044715 |
| 145 | stress granule assembly (GO:0034063) | 2.45518253 |
| 146 | protein retention in ER lumen (GO:0006621) | 2.44100133 |
| 147 | ethanol oxidation (GO:0006069) | 2.40852776 |
| 148 | oxidative phosphorylation (GO:0006119) | 2.37209911 |
| 149 | regulation of cholesterol metabolic process (GO:0090181) | 2.36439098 |
| 150 | positive regulation of Rap GTPase activity (GO:0032854) | 2.36171483 |
| 151 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.35659754 |
| 152 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.35216306 |
| 153 | tricarboxylic acid metabolic process (GO:0072350) | 2.32754796 |
| 154 | regulation of female receptivity (GO:0045924) | 2.32351027 |
| 155 | positive regulation of dendritic spine development (GO:0060999) | 2.32185700 |
| 156 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.31564189 |
| 157 | cellular response to nitric oxide (GO:0071732) | 2.31362750 |
| 158 | detection of calcium ion (GO:0005513) | 2.30965303 |
| 159 | regulation of vesicle fusion (GO:0031338) | 2.30897574 |
| 160 | fatty acid homeostasis (GO:0055089) | 2.30365925 |
| 161 | glucose 6-phosphate metabolic process (GO:0051156) | 2.30233024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.53508318 |
| 2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.64368254 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.62793247 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.61687850 |
| 5 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.49388242 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.49388242 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.48353739 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.47915585 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.41279656 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38141102 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24845659 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.20772520 |
| 13 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.18125046 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.14678328 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12359880 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.12072491 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11274508 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.07473080 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02455952 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96920484 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.95687617 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94653723 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.90644651 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.90206941 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.85375005 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.84458585 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.83962338 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78363161 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78222815 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.76063541 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75163805 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74654330 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72703122 |
| 34 | P68_20966046_ChIP-Seq_HELA_Human | 1.70399984 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70028346 |
| 36 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.69685449 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.69221014 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61369842 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.60656543 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57455091 |
| 41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55858096 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53379227 |
| 43 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52070569 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.49247266 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49069964 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47188646 |
| 47 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.45883765 |
| 48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44988839 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43334435 |
| 50 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.43084295 |
| 51 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43019165 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.42502601 |
| 53 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.42496847 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42093892 |
| 55 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41812142 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41523806 |
| 57 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.37713437 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.37182312 |
| 59 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.36174874 |
| 60 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33469149 |
| 61 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33096240 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32501532 |
| 63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31713400 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30991021 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30605094 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29532015 |
| 67 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29526940 |
| 68 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.28680178 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28660446 |
| 70 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28058883 |
| 71 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.27299953 |
| 72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26994987 |
| 73 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26592758 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25647946 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24957228 |
| 76 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24804390 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24679028 |
| 78 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24225391 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23210197 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22816548 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22695020 |
| 82 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22464558 |
| 83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22266457 |
| 84 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.22090964 |
| 85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19447323 |
| 86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18817703 |
| 87 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17800568 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16593957 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16354885 |
| 90 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.16142621 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16100312 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15585817 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15476229 |
| 94 | AR_19668381_ChIP-Seq_PC3_Human | 1.14587326 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14486236 |
| 96 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.13956174 |
| 97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13728532 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13610689 |
| 99 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12733351 |
| 100 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.12412171 |
| 101 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11622301 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10975440 |
| 103 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10335968 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09343870 |
| 105 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.09058153 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08878140 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08058947 |
| 108 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.07097142 |
| 109 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06644661 |
| 110 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05264543 |
| 111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03694947 |
| 112 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02780156 |
| 113 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.02730881 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02300586 |
| 115 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.01894517 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01853695 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01478596 |
| 118 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01214859 |
| 119 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00994067 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00543388 |
| 121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00508477 |
| 122 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.00396169 |
| 123 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00138025 |
| 124 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.98749282 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98596623 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98540801 |
| 127 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98455020 |
| 128 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97754627 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97364985 |
| 130 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97141293 |
| 131 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96050497 |
| 132 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95823663 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95377729 |
| 134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94254975 |
| 135 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93728583 |
| 136 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.93236949 |
| 137 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93107729 |
| 138 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.92958786 |
| 139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92747314 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92673335 |
| 141 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92419089 |
| 142 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92371180 |
| 143 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92306837 |
| 144 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.91782475 |
| 145 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90208668 |
| 146 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89428744 |
| 147 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89428744 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88472161 |
| 149 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88333427 |
| 150 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88298271 |
| 151 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87984121 |
| 152 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87193778 |
| 153 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87099991 |
| 154 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.86787555 |
| 155 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86291003 |
| 156 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84515939 |
| 157 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83950834 |
| 158 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82511718 |
| 159 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.82508231 |
| 160 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.81916702 |
| 161 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81353730 |
| 162 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81305970 |
| 163 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81303742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.78907951 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.37367468 |
| 3 | MP0002822_catalepsy | 3.23022302 |
| 4 | MP0004043_abnormal_pH_regulation | 2.91755681 |
| 5 | MP0004270_analgesia | 2.91086338 |
| 6 | MP0005670_abnormal_white_adipose | 2.66911386 |
| 7 | MP0003123_paternal_imprinting | 2.66260384 |
| 8 | MP0009745_abnormal_behavioral_response | 2.59265232 |
| 9 | MP0003880_abnormal_central_pattern | 2.58207174 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.44248566 |
| 11 | MP0000751_myopathy | 2.43756767 |
| 12 | MP0002064_seizures | 2.39210716 |
| 13 | MP0000678_abnormal_parathyroid_gland | 2.38024109 |
| 14 | MP0009046_muscle_twitch | 2.37048616 |
| 15 | MP0005409_darkened_coat_color | 2.30698077 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.25547617 |
| 17 | MP0003646_muscle_fatigue | 2.21964767 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.18657577 |
| 19 | MP0002909_abnormal_adrenal_gland | 2.16138269 |
| 20 | MP0001486_abnormal_startle_reflex | 2.11813709 |
| 21 | MP0002272_abnormal_nervous_system | 2.02331893 |
| 22 | MP0004885_abnormal_endolymph | 2.01504930 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.94450029 |
| 24 | MP0008569_lethality_at_weaning | 1.89991930 |
| 25 | MP0005423_abnormal_somatic_nervous | 1.86903880 |
| 26 | MP0004130_abnormal_muscle_cell | 1.86124797 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 1.85649427 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.84729808 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.84118903 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.84055712 |
| 31 | MP0008961_abnormal_basal_metabolism | 1.82907356 |
| 32 | MP0000566_synostosis | 1.73123048 |
| 33 | MP0003329_amyloid_beta_deposits | 1.71260649 |
| 34 | MP0002249_abnormal_larynx_morphology | 1.71165460 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.68812361 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.63366023 |
| 37 | MP0005360_urolithiasis | 1.60621491 |
| 38 | MP0001968_abnormal_touch/_nociception | 1.59163740 |
| 39 | MP0003879_abnormal_hair_cell | 1.57187616 |
| 40 | MP0001440_abnormal_grooming_behavior | 1.56739347 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.53462280 |
| 42 | MP0009672_abnormal_birth_weight | 1.53146765 |
| 43 | MP0004484_altered_response_of | 1.49606557 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.49108522 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.47840127 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.46718603 |
| 47 | MP0000747_muscle_weakness | 1.46325598 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.40575388 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.40012964 |
| 50 | MP0005535_abnormal_body_temperature | 1.38867089 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.36204972 |
| 52 | MP0004858_abnormal_nervous_system | 1.35172139 |
| 53 | MP0005330_cardiomyopathy | 1.34727066 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.33736486 |
| 55 | MP0002796_impaired_skin_barrier | 1.33690501 |
| 56 | MP0005386_behavior/neurological_phenoty | 1.32250383 |
| 57 | MP0004924_abnormal_behavior | 1.32250383 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.31682252 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.29063482 |
| 60 | MP0001970_abnormal_pain_threshold | 1.27728007 |
| 61 | MP0003137_abnormal_impulse_conducting | 1.27377303 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.27049162 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.25697050 |
| 64 | MP0004085_abnormal_heartbeat | 1.22993974 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.22331541 |
| 66 | MP0003195_calcinosis | 1.21823977 |
| 67 | MP0003633_abnormal_nervous_system | 1.21555289 |
| 68 | MP0003690_abnormal_glial_cell | 1.20693675 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.18826698 |
| 70 | MP0005666_abnormal_adipose_tissue | 1.17464917 |
| 71 | MP0005332_abnormal_amino_acid | 1.15735729 |
| 72 | MP0005620_abnormal_muscle_contractility | 1.15638488 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.15085238 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.14483471 |
| 75 | MP0001730_embryonic_growth_arrest | 1.14193335 |
| 76 | MP0005451_abnormal_body_composition | 1.14173966 |
| 77 | MP0004811_abnormal_neuron_physiology | 1.14025766 |
| 78 | MP0004087_abnormal_muscle_fiber | 1.14010457 |
| 79 | MP0002557_abnormal_social/conspecific_i | 1.13226798 |
| 80 | MP0008775_abnormal_heart_ventricle | 1.11643844 |
| 81 | MP0005646_abnormal_pituitary_gland | 1.09903702 |
| 82 | MP0002139_abnormal_hepatobiliary_system | 1.08458460 |
| 83 | MP0003283_abnormal_digestive_organ | 1.07067422 |
| 84 | MP0001346_abnormal_lacrimal_gland | 1.05453229 |
| 85 | MP0002184_abnormal_innervation | 1.05416590 |
| 86 | MP0005058_abnormal_lysosome_morphology | 1.04285423 |
| 87 | MP0001485_abnormal_pinna_reflex | 1.03927400 |
| 88 | MP0008872_abnormal_physiological_respon | 1.03666201 |
| 89 | MP0003787_abnormal_imprinting | 1.03240516 |
| 90 | MP0004233_abnormal_muscle_weight | 1.02662235 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 1.02477225 |
| 92 | MP0010630_abnormal_cardiac_muscle | 1.01704632 |
| 93 | MP0000955_abnormal_spinal_cord | 1.01683909 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 1.01304277 |
| 95 | MP0002970_abnormal_white_adipose | 1.00570455 |
| 96 | MP0002972_abnormal_cardiac_muscle | 0.99592376 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 0.99209611 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.98339453 |
| 99 | MP0006138_congestive_heart_failure | 0.97782613 |
| 100 | MP0005375_adipose_tissue_phenotype | 0.97040550 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.96959594 |
| 102 | MP0005187_abnormal_penis_morphology | 0.95916632 |
| 103 | MP0004147_increased_porphyrin_level | 0.95080066 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.92861694 |
| 105 | MP0003868_abnormal_feces_composition | 0.92414644 |
| 106 | MP0002106_abnormal_muscle_physiology | 0.90993037 |
| 107 | MP0002971_abnormal_brown_adipose | 0.90935221 |
| 108 | MP0003075_altered_response_to | 0.89892235 |
| 109 | MP0009840_abnormal_foam_cell | 0.89251624 |
| 110 | MP0002069_abnormal_eating/drinking_beha | 0.88332485 |
| 111 | MP0009115_abnormal_fat_cell | 0.87313846 |
| 112 | MP0002269_muscular_atrophy | 0.86611942 |
| 113 | MP0002882_abnormal_neuron_morphology | 0.86488082 |
| 114 | MP0008874_decreased_physiological_sensi | 0.86296601 |
| 115 | MP0002735_abnormal_chemical_nociception | 0.85919361 |
| 116 | MP0003631_nervous_system_phenotype | 0.85776498 |
| 117 | MP0000920_abnormal_myelination | 0.85140991 |
| 118 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84989373 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.84819142 |
| 120 | MP0010329_abnormal_lipoprotein_level | 0.84687964 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.84194073 |
| 122 | MP0001984_abnormal_olfaction | 0.83421606 |
| 123 | MP0001177_atelectasis | 0.82592635 |
| 124 | MP0001731_abnormal_postnatal_growth | 0.82314473 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.81908289 |
| 126 | MP0000749_muscle_degeneration | 0.81816037 |
| 127 | MP0005365_abnormal_bile_salt | 0.81281046 |
| 128 | MP0002736_abnormal_nociception_after | 0.80902536 |
| 129 | MP0005448_abnormal_energy_balance | 0.80351355 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78900366 |
| 131 | MP0001849_ear_inflammation | 0.78699259 |
| 132 | MP0005385_cardiovascular_system_phenoty | 0.78659958 |
| 133 | MP0001544_abnormal_cardiovascular_syste | 0.78659958 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.78465837 |
| 135 | MP0005369_muscle_phenotype | 0.78058134 |
| 136 | MP0009643_abnormal_urine_homeostasis | 0.77967603 |
| 137 | MP0005636_abnormal_mineral_homeostasis | 0.77041104 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.76521185 |
| 139 | MP0002078_abnormal_glucose_homeostasis | 0.74697935 |
| 140 | MP0001664_abnormal_digestion | 0.74466175 |
| 141 | MP0001881_abnormal_mammary_gland | 0.74094412 |
| 142 | MP0003953_abnormal_hormone_level | 0.73773877 |
| 143 | MP0005452_abnormal_adipose_tissue | 0.71631538 |
| 144 | MP0000462_abnormal_digestive_system | 0.71012480 |
| 145 | MP0001944_abnormal_pancreas_morphology | 0.68335547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.46190973 |
| 2 | Focal motor seizures (HP:0011153) | 5.04420278 |
| 3 | Visual hallucinations (HP:0002367) | 4.38220845 |
| 4 | Ventricular fibrillation (HP:0001663) | 4.29923013 |
| 5 | Obstructive sleep apnea (HP:0002870) | 4.22762406 |
| 6 | Bundle branch block (HP:0011710) | 3.98812276 |
| 7 | Action tremor (HP:0002345) | 3.93089149 |
| 8 | Focal seizures (HP:0007359) | 3.80515301 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.31455447 |
| 10 | Gout (HP:0001997) | 3.31062273 |
| 11 | Truncus arteriosus (HP:0001660) | 3.23551365 |
| 12 | Abnormal gallbladder physiology (HP:0012438) | 3.09214771 |
| 13 | Cholecystitis (HP:0001082) | 3.09214771 |
| 14 | Abnormal social behavior (HP:0012433) | 3.06117018 |
| 15 | Impaired social interactions (HP:0000735) | 3.06117018 |
| 16 | Increased circulating renin level (HP:0000848) | 3.01828676 |
| 17 | Dysdiadochokinesis (HP:0002075) | 2.99865199 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 2.98862889 |
| 19 | Sudden death (HP:0001699) | 2.96821843 |
| 20 | Poor eye contact (HP:0000817) | 2.92259102 |
| 21 | Depression (HP:0000716) | 2.92196081 |
| 22 | Atrioventricular block (HP:0001678) | 2.90298419 |
| 23 | Anxiety (HP:0000739) | 2.89912866 |
| 24 | Dysmetric saccades (HP:0000641) | 2.89493019 |
| 25 | Heart block (HP:0012722) | 2.88488783 |
| 26 | Generalized tonic-clonic seizures (HP:0002069) | 2.82104343 |
| 27 | Deep venous thrombosis (HP:0002625) | 2.81745153 |
| 28 | Hyperglycinuria (HP:0003108) | 2.80673779 |
| 29 | Hyperthyroidism (HP:0000836) | 2.79253228 |
| 30 | Absence seizures (HP:0002121) | 2.78773091 |
| 31 | Ankle clonus (HP:0011448) | 2.78327377 |
| 32 | Postural instability (HP:0002172) | 2.78254826 |
| 33 | Papilledema (HP:0001085) | 2.77977400 |
| 34 | Distal upper limb amyotrophy (HP:0007149) | 2.68724841 |
| 35 | Upper limb amyotrophy (HP:0009129) | 2.68724841 |
| 36 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.67547277 |
| 37 | Intention tremor (HP:0002080) | 2.63285756 |
| 38 | Dysmetria (HP:0001310) | 2.62897058 |
| 39 | Growth hormone excess (HP:0000845) | 2.60840370 |
| 40 | Genetic anticipation (HP:0003743) | 2.58545972 |
| 41 | Myoglobinuria (HP:0002913) | 2.58314311 |
| 42 | Hemiplegia (HP:0002301) | 2.57657038 |
| 43 | Syncope (HP:0001279) | 2.56916598 |
| 44 | Atonic seizures (HP:0010819) | 2.56824556 |
| 45 | Broad-based gait (HP:0002136) | 2.56799544 |
| 46 | Metabolic alkalosis (HP:0200114) | 2.56327608 |
| 47 | Prolonged QT interval (HP:0001657) | 2.55720194 |
| 48 | Ketoacidosis (HP:0001993) | 2.55691547 |
| 49 | Hypokalemic alkalosis (HP:0001949) | 2.55392030 |
| 50 | Abnormal atrioventricular conduction (HP:0005150) | 2.54262484 |
| 51 | Urethral obstruction (HP:0000796) | 2.52746464 |
| 52 | Ankyloglossia (HP:0010296) | 2.49665423 |
| 53 | Hypercortisolism (HP:0001578) | 2.49471505 |
| 54 | Neurofibrillary tangles (HP:0002185) | 2.47885044 |
| 55 | Hyperparathyroidism (HP:0000843) | 2.47523153 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.45429527 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.45429527 |
| 58 | Hyperacusis (HP:0010780) | 2.42018327 |
| 59 | Torticollis (HP:0000473) | 2.41946201 |
| 60 | Ventricular arrhythmia (HP:0004308) | 2.41781233 |
| 61 | Urinary urgency (HP:0000012) | 2.41355421 |
| 62 | Dialeptic seizures (HP:0011146) | 2.41234119 |
| 63 | Gaze-evoked nystagmus (HP:0000640) | 2.41218259 |
| 64 | Abnormal eating behavior (HP:0100738) | 2.38912762 |
| 65 | Abnormal EKG (HP:0003115) | 2.38255561 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.37795339 |
| 67 | Diplopia (HP:0000651) | 2.37795339 |
| 68 | Exercise-induced muscle cramps (HP:0003710) | 2.37652996 |
| 69 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.37562327 |
| 70 | Bronchomalacia (HP:0002780) | 2.35006111 |
| 71 | Abnormality of glycolysis (HP:0004366) | 2.34840491 |
| 72 | Supranuclear gaze palsy (HP:0000605) | 2.33739518 |
| 73 | Hyperglycinemia (HP:0002154) | 2.33043387 |
| 74 | Cerebral hypomyelination (HP:0006808) | 2.31468046 |
| 75 | Seborrheic dermatitis (HP:0001051) | 2.31190696 |
| 76 | Peripheral hypomyelination (HP:0007182) | 2.29118487 |
| 77 | Ketosis (HP:0001946) | 2.28347978 |
| 78 | Abnormality of the lower motor neuron (HP:0002366) | 2.26048752 |
| 79 | Difficulty running (HP:0009046) | 2.24863406 |
| 80 | Pheochromocytoma (HP:0002666) | 2.24799032 |
| 81 | Cerebral inclusion bodies (HP:0100314) | 2.24368594 |
| 82 | Status epilepticus (HP:0002133) | 2.24269734 |
| 83 | Atrial fibrillation (HP:0005110) | 2.23000021 |
| 84 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.22596049 |
| 85 | Bowel incontinence (HP:0002607) | 2.22476069 |
| 86 | Hyperphosphatemia (HP:0002905) | 2.22397130 |
| 87 | Hand muscle atrophy (HP:0009130) | 2.22113620 |
| 88 | Tetraplegia (HP:0002445) | 2.21783963 |
| 89 | Focal dystonia (HP:0004373) | 2.21757981 |
| 90 | Increased nuchal translucency (HP:0010880) | 2.20635566 |
| 91 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.20606696 |
| 92 | Epileptic encephalopathy (HP:0200134) | 2.18214572 |
| 93 | Annular pancreas (HP:0001734) | 2.17510176 |
| 94 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.17394217 |
| 95 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.15137820 |
| 96 | Primary atrial arrhythmia (HP:0001692) | 2.14953624 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 2.13664524 |
| 98 | Febrile seizures (HP:0002373) | 2.13297615 |
| 99 | Abnormality of the salivary glands (HP:0010286) | 2.13042727 |
| 100 | Stridor (HP:0010307) | 2.09393587 |
| 101 | Adrenal overactivity (HP:0002717) | 2.09023332 |
| 102 | Hypoglycemic coma (HP:0001325) | 2.08557260 |
| 103 | Mutism (HP:0002300) | 2.08020483 |
| 104 | Muscle fiber splitting (HP:0003555) | 2.06610492 |
| 105 | Increased purine levels (HP:0004368) | 2.05319594 |
| 106 | Hyperuricemia (HP:0002149) | 2.05319594 |
| 107 | Akinesia (HP:0002304) | 2.03822471 |
| 108 | Craniofacial dystonia (HP:0012179) | 2.00726000 |
| 109 | Calf muscle hypertrophy (HP:0008981) | 2.00710885 |
| 110 | Supraventricular tachycardia (HP:0004755) | 1.98016346 |
| 111 | Abnormal large intestine physiology (HP:0012700) | 1.97562969 |
| 112 | J-shaped sella turcica (HP:0002680) | 1.96105991 |
| 113 | Hemorrhage of the eye (HP:0011885) | 1.94773000 |
| 114 | Insomnia (HP:0100785) | 1.93394642 |
| 115 | Reticulocytosis (HP:0001923) | 1.93288777 |
| 116 | Delayed CNS myelination (HP:0002188) | 1.93076605 |
| 117 | Progressive inability to walk (HP:0002505) | 1.92159037 |
| 118 | Supraventricular arrhythmia (HP:0005115) | 1.91800242 |
| 119 | Hyperactive renin-angiotensin system (HP:0000841) | 1.91466560 |
| 120 | Right ventricular cardiomyopathy (HP:0011663) | 1.91232826 |
| 121 | Atelectasis (HP:0100750) | 1.91160554 |
| 122 | Rigidity (HP:0002063) | 1.90830898 |
| 123 | Hyperaldosteronism (HP:0000859) | 1.90208402 |
| 124 | Scanning speech (HP:0002168) | 1.89855064 |
| 125 | Lower limb asymmetry (HP:0100559) | 1.88361723 |
| 126 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.87984556 |
| 127 | Abnormality of renin-angiotensin system (HP:0000847) | 1.87904245 |
| 128 | Impaired smooth pursuit (HP:0007772) | 1.87604238 |
| 129 | Spastic gait (HP:0002064) | 1.87332552 |
| 130 | Resting tremor (HP:0002322) | 1.84671083 |
| 131 | Megalencephaly (HP:0001355) | 1.84071147 |
| 132 | Bradykinesia (HP:0002067) | 1.83923135 |
| 133 | Hyperammonemia (HP:0001987) | 1.83564817 |
| 134 | Impaired vibratory sensation (HP:0002495) | 1.82861969 |
| 135 | Hyperkalemia (HP:0002153) | 1.82309443 |
| 136 | Late onset (HP:0003584) | 1.81694248 |
| 137 | Truncal ataxia (HP:0002078) | 1.81492998 |
| 138 | Postural tremor (HP:0002174) | 1.81082422 |
| 139 | Abnormality of saccadic eye movements (HP:0000570) | 1.79913293 |
| 140 | Macroorchidism (HP:0000053) | 1.79177126 |
| 141 | Neuroendocrine neoplasm (HP:0100634) | 1.78763070 |
| 142 | Agitation (HP:0000713) | 1.78303534 |
| 143 | Testicular neoplasm (HP:0010788) | 1.77448151 |
| 144 | Abnormality of cochlea (HP:0000375) | 1.76748814 |
| 145 | Insidious onset (HP:0003587) | 1.76427795 |
| 146 | Termporal pattern (HP:0011008) | 1.76427795 |
| 147 | Renal salt wasting (HP:0000127) | 1.76340300 |
| 148 | Hyporeflexia of lower limbs (HP:0002600) | 1.75664568 |
| 149 | Increased serum pyruvate (HP:0003542) | 1.75393790 |
| 150 | Hammertoe (HP:0001765) | 1.75331800 |
| 151 | Ileus (HP:0002595) | 1.75269043 |
| 152 | Hypoglycemic seizures (HP:0002173) | 1.73505830 |
| 153 | Foot dorsiflexor weakness (HP:0009027) | 1.72627073 |
| 154 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71264982 |
| 155 | Athetosis (HP:0002305) | 1.71225183 |
| 156 | Pili torti (HP:0003777) | 1.70722483 |
| 157 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.69658173 |
| 158 | Morphological abnormality of the inner ear (HP:0011390) | 1.69643603 |
| 159 | Myopathic facies (HP:0002058) | 1.68729658 |
| 160 | Unilateral renal agenesis (HP:0000122) | 1.68095961 |
| 161 | Sleep apnea (HP:0010535) | 1.67225538 |
| 162 | Attention deficit hyperactivity disorder (HP:0007018) | 1.66164388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.48418193 |
| 2 | EPHA4 | 3.35260763 |
| 3 | MAP3K9 | 3.29881872 |
| 4 | PRKD3 | 3.05723529 |
| 5 | CDK12 | 2.92672478 |
| 6 | KSR2 | 2.54953678 |
| 7 | SMG1 | 2.52226266 |
| 8 | PRPF4B | 2.49770421 |
| 9 | PAK6 | 2.34724558 |
| 10 | SIK1 | 2.25654100 |
| 11 | MAP3K4 | 2.25365728 |
| 12 | DAPK2 | 2.20396000 |
| 13 | ICK | 2.17264997 |
| 14 | STK38 | 2.17264868 |
| 15 | TRIB3 | 2.17081652 |
| 16 | CAMKK1 | 2.14729610 |
| 17 | MST1R | 2.06008210 |
| 18 | LMTK2 | 2.04076662 |
| 19 | MINK1 | 2.03788550 |
| 20 | EPHA2 | 2.01840883 |
| 21 | NEK1 | 1.99828675 |
| 22 | FGFR4 | 1.97130761 |
| 23 | TAOK1 | 1.92734732 |
| 24 | EEF2K | 1.91311778 |
| 25 | MAP2K4 | 1.89576466 |
| 26 | WNK4 | 1.87868226 |
| 27 | ERN1 | 1.79074907 |
| 28 | EIF2AK1 | 1.72885036 |
| 29 | PINK1 | 1.61754302 |
| 30 | PHKG2 | 1.60522332 |
| 31 | PHKG1 | 1.60522332 |
| 32 | RIPK1 | 1.55383018 |
| 33 | MAP3K2 | 1.52592008 |
| 34 | NTRK2 | 1.48161260 |
| 35 | OXSR1 | 1.47769430 |
| 36 | PDK4 | 1.43230073 |
| 37 | PDK3 | 1.43230073 |
| 38 | NTRK1 | 1.43221265 |
| 39 | MARK1 | 1.43141853 |
| 40 | WNK1 | 1.41713011 |
| 41 | TYRO3 | 1.41005502 |
| 42 | CAMK1 | 1.23387833 |
| 43 | MAP2K7 | 1.22955999 |
| 44 | CDK5 | 1.22680112 |
| 45 | WNK3 | 1.21240678 |
| 46 | ALK | 1.19448776 |
| 47 | CAMK1G | 1.18281189 |
| 48 | STK11 | 1.17785584 |
| 49 | DMPK | 1.17706458 |
| 50 | CAMKK2 | 1.15496483 |
| 51 | PAK3 | 1.15021103 |
| 52 | PRKCH | 1.12860406 |
| 53 | MAP3K7 | 1.12719205 |
| 54 | KSR1 | 1.11974119 |
| 55 | MAP3K13 | 1.11830101 |
| 56 | NEK6 | 1.10772593 |
| 57 | MAPKAPK3 | 1.10678843 |
| 58 | NME1 | 1.10275956 |
| 59 | PDPK1 | 1.04825686 |
| 60 | RET | 1.03566965 |
| 61 | PKN2 | 1.03022697 |
| 62 | FGFR3 | 1.02730516 |
| 63 | TTK | 1.02713391 |
| 64 | LATS2 | 1.02484175 |
| 65 | PDK1 | 1.00979589 |
| 66 | STK39 | 0.98781939 |
| 67 | CDK19 | 0.94631445 |
| 68 | SGK3 | 0.92547031 |
| 69 | SGK494 | 0.91213038 |
| 70 | SGK223 | 0.91213038 |
| 71 | PRKCG | 0.90407690 |
| 72 | PRKG2 | 0.89772002 |
| 73 | MET | 0.85856256 |
| 74 | MAP3K1 | 0.84789558 |
| 75 | MTOR | 0.84039294 |
| 76 | TNIK | 0.83377905 |
| 77 | MAPKAPK5 | 0.82783245 |
| 78 | MAP3K10 | 0.81204062 |
| 79 | RPS6KB2 | 0.77844100 |
| 80 | ARAF | 0.77401380 |
| 81 | BMPR2 | 0.77054816 |
| 82 | BRD4 | 0.76882359 |
| 83 | SIK2 | 0.76814978 |
| 84 | HIPK2 | 0.74297341 |
| 85 | PTK6 | 0.72961350 |
| 86 | CAMK1D | 0.72641527 |
| 87 | RIPK4 | 0.72596916 |
| 88 | CDC42BPA | 0.71440679 |
| 89 | BMX | 0.71299267 |
| 90 | MAPK12 | 0.70774825 |
| 91 | BCKDK | 0.70530667 |
| 92 | PTK2 | 0.70442359 |
| 93 | TESK1 | 0.69227716 |
| 94 | UHMK1 | 0.68443652 |
| 95 | FES | 0.68390512 |
| 96 | SGK1 | 0.68281361 |
| 97 | SGK2 | 0.67756245 |
| 98 | SIK3 | 0.67186581 |
| 99 | CAMK2A | 0.66778720 |
| 100 | TNK2 | 0.66646237 |
| 101 | RAF1 | 0.64444608 |
| 102 | MAP2K6 | 0.64365165 |
| 103 | GRK5 | 0.63197570 |
| 104 | CAMK4 | 0.62962998 |
| 105 | PDGFRA | 0.60846025 |
| 106 | CAMK2G | 0.60721990 |
| 107 | DAPK1 | 0.60578206 |
| 108 | RPS6KA3 | 0.60212672 |
| 109 | PNCK | 0.59966762 |
| 110 | MAPK11 | 0.57458052 |
| 111 | CSNK1G2 | 0.56853763 |
| 112 | PDK2 | 0.56344685 |
| 113 | PRKAA1 | 0.56319798 |
| 114 | PRKD1 | 0.55896010 |
| 115 | SCYL2 | 0.55589999 |
| 116 | MAP2K2 | 0.55094465 |
| 117 | BRSK1 | 0.54929222 |
| 118 | MAPK10 | 0.53228058 |
| 119 | CDK9 | 0.53135472 |
| 120 | MARK2 | 0.52095452 |
| 121 | CAMK2D | 0.51584371 |
| 122 | OBSCN | 0.51131577 |
| 123 | MAPK15 | 0.46190508 |
| 124 | CDK7 | 0.44219929 |
| 125 | PRKCZ | 0.43980099 |
| 126 | CDK4 | 0.43685216 |
| 127 | CDK14 | 0.43456788 |
| 128 | WEE1 | 0.43211665 |
| 129 | CDK15 | 0.42896534 |
| 130 | PRKACG | 0.42085300 |
| 131 | DYRK1A | 0.41268962 |
| 132 | CAMK2B | 0.41043183 |
| 133 | GSK3B | 0.40673973 |
| 134 | FGFR2 | 0.40185270 |
| 135 | MUSK | 0.38341642 |
| 136 | MAP2K1 | 0.38212653 |
| 137 | FER | 0.38011126 |
| 138 | CDK11A | 0.37514263 |
| 139 | PRKAA2 | 0.37314573 |
| 140 | PRKCI | 0.37103946 |
| 141 | EPHB1 | 0.36980329 |
| 142 | CDK18 | 0.36913063 |
| 143 | CSNK1E | 0.36775438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38871280 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.78365071 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.30922103 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.14772325 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.12254666 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.12063043 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.11816464 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02878000 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.02576456 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.98319399 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.97000757 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.84753280 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84509013 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.83788654 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.83221263 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.79486918 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.79161328 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78307753 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75519872 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.72070921 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69843114 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.69608532 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.69444746 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63656961 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.57399171 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52892307 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.49665620 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49590761 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45895877 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45098913 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42580097 |
| 32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.42144480 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.42112783 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.40898423 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33559494 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29922895 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28763435 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28699214 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.27747053 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.25317451 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25263503 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.22568081 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22163156 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20652306 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18395257 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18307797 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17070561 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16281188 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14107807 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 1.09672138 |
| 51 | Prion diseases_Homo sapiens_hsa05020 | 1.09088475 |
| 52 | Long-term depression_Homo sapiens_hsa04730 | 1.07236034 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02413924 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.02306284 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.97111094 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95380628 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 0.93042228 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93003385 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92803152 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.91947239 |
| 61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90528593 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.87091434 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86660626 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86385533 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.85175560 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83883740 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83640585 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81732324 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80863035 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80703921 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79924479 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79278825 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78311749 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.78107529 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77871611 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74821599 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71723268 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71550010 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.71500246 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.70615495 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68633823 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68445449 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66143947 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65291393 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64350840 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64234035 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63841587 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.63666853 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63438869 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62505587 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62229220 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61978311 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60287009 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60102994 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59933226 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59797409 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59242150 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59225417 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59222663 |
| 100 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56361776 |
| 101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56348458 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56337218 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56085465 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54632178 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54293031 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53312082 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.52994193 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50744348 |
| 109 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49679346 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49406145 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49338579 |
| 112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47774078 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47120071 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46796255 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46727678 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45836961 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.44941900 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43576702 |
| 119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43189631 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41495630 |
| 121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40459971 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40422038 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40291554 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39561072 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36566831 |
| 126 | Axon guidance_Homo sapiens_hsa04360 | 0.35099319 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34929882 |

